A significant advance in cancer research is arising with the use of mini-antibodies to restore dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in many forms of malignancies, leading https://bookmarkstumble.com/story24059606/vhh-fragments-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-management